Latest News

STAT Plus: Pharmalittle: Company buys drug and raises price 70 percent; Oklahoma opioid trial is the one to watch

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to chaperone our shortest person for more lessons in the vintage driving machine, check in on the Pharmalot ancestors, and catch up on some reading and napping. And what about you? This is a good time to make time for someone special or plan a spring break. Or you could place bets on the likelihood that a wall gets built on a certain border. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The day after Egalet bought Zorvolex, an anti-inflammatory pain reliever, the company boosted the price by nearly 70 percent, which represents the largest single brand price hike in over a year, Axios writes, citing 46Brooklyn, a nonprofit research firm that tracks pricing. As of Feb. 1, a 90-pill bottle now has a price tag of $650, compared with $383 a year ago, according to Elsevier’s Gold Standard Drug Database. The previous owner, Iroko Pharmaceutical, already raised the price by 9.4 percent on Jan. 9, making this the only drug to experience more than one increase this year.

Continue to STAT Plus to read the full story…

Source link

Related posts

Medical News Today: Why do I feel tingling in my face?


5 Most Competitive Residency Programs in US


Medical News Today: What is modern medicine?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy